Protocol summary

Study aim
Comparison of Remifentanil use in spinal surgery under general anesthesia in two groups under ANI monitoring and without ANI monitoring
Design
Block and single-blind randomized clinical trial in phase 3 on 60 patients undergoing general anesthesia for spinal surgery, in two parallel control and intervention groups, with and without ANI monitoring.
Settings and conduct
In this study, a single-blind randomized clinical trial for a researcher, by not stating the size of randomization blocks, patients undergoing general anesthesia for spinal surgery at Sina Hospital in Tehran were randomly divided into two groups with and without ANI monitoring. During surgery, depending on the BIS, between 40 and 60 infusions of propofol are administered in both groups and according to ANI values, between 50 and 70 infusions of remifentanil are prescribed in the group under ANI guidance.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Patients between 18 and 70 years old, patients candidates for spinal surgery, ASA grade I-II and consent to study. Exclusion criteria: Patients with arrhythmia, patients taking beta-blockers, patients with neuromuscular diseases, diabetics and pregnant women, patients for whom pre- or postoperative ANI monitoring should be discontinued, patients who require Transfer to ICU without postoperative awakening, patients who had received medication before the intervention, lack of patient cooperation, drug addiction.
Intervention groups
Control group: Candidate patients for spinal surgery under general anesthesia without ANI monitoring; Intervention group: Candidate patients for spinal surgery under general anesthesia under the guidance of ANI monitoring
Main outcome variables
The amount of remifentanil used during surgery; the amount of pain in recovery; The incidence of complications due to the administration of Remifentanyl.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20180303038923N1
Registration date: 2022-07-05, 1401/04/14
Registration timing: retrospective

Last update: 2022-07-05, 1401/04/14
Update count: 0
Registration date
2022-07-05, 1401/04/14
Registrant information
Name
Farsad Imani
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 4402 6720
Email address
imanifar@tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-05-21, 1397/02/31
Expected recruitment end date
2019-06-19, 1398/03/29
Actual recruitment start date
2018-05-21, 1397/02/31
Actual recruitment end date
2019-06-19, 1398/03/29
Trial completion date
2020-08-19, 1399/05/29
Scientific title
Comparison of Remifentanil use in spinal surgery with and without ANI(analgesia nociception Index) monitoring guidance
Public title
Comparison of Remifentanil use in spinal surgery with and without ANI monitoring guidance
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients between 18 and 70 years Patients candidate for spine surgery ASA Grade I-II Consent to enter the study
Exclusion criteria:
Patients taking beta-blocker drugs
Age
From 18 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 60
Actual sample size reached: 58
Randomization (investigator's opinion)
Randomized
Randomization description
The eligible patients were randomly assigned to the treatment and control groups using balanced block randomization with a block size of four. For this purpose, the treatment and control groups were randomly assigned to letters A and B. Thus, for each block of four patients, two sequence different assignments were made for each treatment. Six sheets of paper were used. In the papers were written all the possible states, i.e. Paper No. 1 for AABB, Paper No. 2 for ABAB, Paper No. 3 for ABBA, Paper No. 4 for BBAA, Paper No. 5 for BABA, and Paper No. 6 or BAAB. Then the number were selected randomly via table of random numbers. According to number of selected papers, the patients respectively were in the treatment or control groups.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tehran university of medical science in
Street address
Sina hospital, Imam Khomeini St, Tehran
City
Tehran
Province
Tehran
Postal code
۱۱۳۶۷۴۶۹۱۱
Approval date
2019-09-02, 1398/06/11
Ethics committee reference number
IR.TUMS.MEDICINEREC.1398.479

Health conditions studied

1

Description of health condition studied
Remifentanil use in surgery with Analgesia Nociception Index
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Dosage of remifentanil during surgery
Timepoint
During surgery
Method of measurement
The amount of remifentanil consumed

Secondary outcomes

1

Description
The rate of pain in recovery in patients
Timepoint
10, 20, 30 and 60 minutes during recovery
Method of measurement
Visual Analogue Scale

2

Description
Further drop in arterial blood saturation below 90% for 60 seconds
Timepoint
10, 20, 30 and 60 minutes during recovery
Method of measurement
Pulse oximetry

3

Description
Complications of fentanyl remedies
Timepoint
During recovery
Method of measurement
According to the recovery nurse

4

Description
Global Satisfaction of patients at the end of recovery
Timepoint
At the end of recovery
Method of measurement
Based on 5 point criteria (poor, average, good, very good and excellent)

Intervention groups

1

Description
Control group: Patients who are candidates for spinal surgery who undergo general anesthesia without ANI monitoring.
Category
Treatment - Other

2

Description
Intervention group: Patients who are candidates for spinal surgery who undergo general anesthesia under the guidance of ANI monitoring.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Sina hospital
Full name of responsible person
Farsad Imani
Street address
Sina hospital, Imam Khomeini St
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1278
Email
Imanifar@tums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farsad imani
Street address
Sina hospital, Imam Khomeini St.
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1278
Email
imanifar@tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farsad Imani
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Sina hospital, Imam Khomeini St
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1278
Email
imanifar@tums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farsad Imani
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Sina Hospital, Imam Khomeini St
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1278
Email
imanifar@tums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Farsad Imani
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Sina hospital, Imam Khomeini St
City
Tehran
Province
Tehran
Postal code
1136746911
Phone
+98 21 6312 1278
Email
imanifar@tums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Loading...